Daiichi Sankyo: Colorectal Neoplasms trials

The registry lists 12 Colorectal Neoplasms studies with Daiichi Sankyo as lead sponsor. 1 are open to participants now and 7 have results posted.

Phase 1 5Phase 2 8No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)RecruitingNCT06330064Phase 1/2
• Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal CancerCompletedNCT04744831Phase 2Results posted
• A Study to Evaluate U3-1402 in Subjects With Advanced or Metastatic Colorectal CancerTerminatedNCT04479436Phase 2Results posted
• DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01)CompletedNCT03384940Phase 2Results posted
• ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal CancerCompletedNCT01075048Phase 1/2Results posted
• Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line ChemotherapyTerminatedNCT00986440Phase 2Results posted
• Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line TherapyCompletedNCT00967616Phase 2Results posted
• Safety Study of PLX4032 in Patients With Solid TumorsCompletedNCT00405587Phase 1Results posted
• Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal CancerTerminatedNCT02991196Phase 1
• Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other TreatmentsCompletedNCT01124630Phase 1
• An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC)CompletedNCT01039506
• CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With OxaliplatinTerminatedNCT00969033Phase 2